SCT treatment guidelines

Indication for alloSCT in haematological disorders

The SCT working group advice is that for the indication for autologous stem cell transplants in non-haematological syndromes, the relevant professional associations should be consulted.

Allo SCT Indications EBMT

---

Advice on procedures for related stem cell donors

Adviezen procedures stamceldonoren (June 2022) (Dutch only)
Appendix A.  questionnaire on HLA type  (June 2022) (Dutch only)
Guidelines for screening of hematopoietic stem cell donors on blood-transferable pathogens outside the standard package (Dutch only)
Questionnaire for the assessment of a stem cell / lymphocyte donor (Dutch only)
Appendix D. Exclusion criteria for assessment (revision June 2022) (Dutch only)
Appendix E. Questionnaire aftercare (Dutch only)

---

Donor selection guide

Selection guide for an unrelated donor (Dutch only)
Selection guide for haplo-identical donor (Dutch only)
Selection guide for cord blood units (Dutch only)

---

Consent forms

Related donor consent (Dutch only)
Unrelated donor consent (Dutch only)

---

Plerixafor medication guideline

Guideline plerixafor (Dutch only)

---

Conditioning advice

Guidelines for conditioning AML TCD (Dutch only)

---

Guideline GVHD

Removed, a new version will be posted as soon as possible.

---

Long-term follow-up recommendations after allogeneic SCT

Recommendations after alloSCT (Dutch only)